KOSDAQOthers046120

Orbitech

₩2,865▲ 1.24%2026-11-18 close
Market Cap
₩97B
Turnover
₩300M
Volume
100K
Shares out.
33.9M
PER
—
PBR
0.8×
EPS
-₩306
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Nuclear Decommissioning and Aerospace Widen Scope, Losses Persist

Orbitech is building nuclear decommissioning and aerospace parts as new pillars, but operating losses have continued for five straight quarters since the 2025 swing to an annual operating loss.

  1. 1

    2025 annual revenue fell 12.9% to KRW 57.9 billion, and operating results swung to a loss of KRW 14 billion.

  2. 2

    Quarterly revenue peaked at KRW 22.4 billion in Q1 2026, then declined to KRW 16.6 billion in Q2 and KRW 12 billion in Q3.

  3. 3

    Controlling-shareholder net losses over the last four quarters total KRW 8.99 billion, and Q1 2026 was the only profitable quarter at KRW 19.1 billion.

  4. 4

    Nuclear decommissioning is tied to Kori Unit 1 and Wolsong Unit 1 approvals, while aerospace accounted for 38% of sales according to a December 2025 report.

  5. 5

    In April 2026 the company sold part of its stake in an affiliate, keeping 17.81% as a strategic investor.

02

Business structure

Orbitech was founded in 1991 as a nuclear power and radiation management company and runs three business pillars: nuclear operations, ISI (in-service inspection) services, and aerospace.

The nuclear unit handles pre- and in-service inspection of nuclear plants, radiation management services, and regulatory release of radioactive waste. It has been performing dismantling services for RI waste facilities for the Korea Radioactive-Waste Agency (KORAD) from 2021 through 2028.

The aerospace unit obtained AS9100 certification and is widening its machined aircraft parts business, including a supply contract with Korea Aerospace Industries (KAI) for KF-21 machined components. A December 2025 report put aerospace at 38% of total sales.

On decommissioning, a government-supported decontamination facility can process up to 1.8 tonnes of radioactive metal waste per day, and a separate line handles 700 kg of concrete waste daily. Both are housed at a decommissioning research institute that opened in December 2025.

The SMR business is at the memorandum of understanding stage with a U.S. thorium-based SMR developer. Main customers are nuclear plant operators, public waste management bodies and domestic aircraft manufacturers.

Competitive positioning rests on combining radiation management with decontamination technology, and the company claims a leading domestic position in decommissioning and radioactive waste treatment. In April 2026 it sold part of its stake in an affiliate and now holds 17.81% as a strategic investor.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩13.9B-₩2.1B−15.4%
2025Q4₩15.5B-₩6B−39.0%
2026Q1₩22.4B-₩3.1B−13.8%
2026Q2₩16.6B-₩1.4B−8.4%
2026Q3₩12B-₩3.1B−25.8%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩59.2B-₩11.8B-₩13.4B−19.8%−23.7%106.6%
2023₩64B-₩4.3B-₩2.2B−6.8%−4.3%93.1%
2024₩66.5B₩700M₩2.2B1.0%3.8%89.4%
2025₩57.9B-₩14B₩800M−24.2%1.3%109.2%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-17

04

Earnings analysis

On a annual basis, revenue rose from KRW 59.2 billion in 2022 to KRW 64 billion in 2023 (up 8.1% year on year) and KRW 66.5 billion in 2024 (up 3.9%), then fell to KRW 57.9 billion in 2025 (down 12.9%). Among 2022 to 2025, 2024 was the largest year and 2025 the smallest.

Operating losses of KRW 11.8 billion in 2022 and KRW 4.33 billion in 2023 narrowed, and 2024 brought an operating profit of KRW 689 million, a swing to profit. In 2025 an operating loss of KRW 14 billion returned the company to loss, with an operating margin of -24.2%.

The company attributed the 2025 decline to lower sales across all business units, higher outsourcing costs, and higher cost of sales from inventory valuation effects. Controlling-shareholder net profit fell 63.2% from KRW 2.15 billion in 2024 to KRW 793 million in 2025.

Net profit was positive despite the operating loss, which means non-operating items added to earnings. Operating cash flow moved from KRW 3.11 billion in 2024 to -KRW 6.27 billion in 2025.

The debt ratio rose from 89.4% in 2024 to 109.2% in 2025, when total liabilities stood at KRW 121.3 billion and total equity at KRW 111.1 billion, of which controlling-shareholder equity was KRW 62.5 billion.

Quarterly revenue rose from KRW 13.9 billion in Q3 2025 to KRW 15.5 billion in Q4 (up 11.6% quarter on quarter), peaking at KRW 22.4 billion in Q1 2026 (up 44.9%). It then fell to KRW 16.6 billion in Q2 (down 26.0%) and KRW 12 billion in Q3 (down 27.9%), two consecutive quarterly declines.

Operating losses have run for five consecutive quarters from Q3 2025 through Q3 2026. In Q3 2025 the company said revenue fell because order timing slipped.

Q1 2026 posted an operating loss of KRW 3.09 billion yet a controlling-shareholder net profit of KRW 19.1 billion, while Q2 and Q3 2026 recorded controlling-shareholder net losses of KRW 5.08 billion and KRW 11.5 billion.

05

Industry analysis

Nuclear decommissioning demand is described as structurally rising as the number of aging reactors grows. In Korea, approvals for Kori Unit 1 and Wolsong Unit 1 are cited as the trigger that opens the market.

CEO Do Eun-seong said approval for those two units alone would open a decommissioning market worth KRW 3 trillion over ten years, a company view that should be read apart from independent industry estimates.

Decontamination and regulatory release technologies for radioactive metal and concrete waste are presented as the core capabilities. The company says it has carried out government-supported R&D and advance projects for more than a decade.

On the operating-reactor side, demand for pre- and in-service inspection and radiation management is described as gradually growing. In aerospace, the company expects results to improve once Boeing production volumes recover to pre-COVID levels.

In defense aerospace, the KF-21 machined parts contract is seen as a route to wider defense supply opportunities. Few independent indicators show where the sector sits in its cycle, so the size of the decommissioning market and the order flow are best gauged through company announcements and government approval timing.

06

Outlook

The company's medium-term target is KRW 100 billion in revenue by 2028, which requires a substantial increase from KRW 57.9 billion in 2025. Reaching it depends on whether orders actually follow the nuclear decommissioning approvals.

A company profile notes that several projects, including radioactive waste decontamination technology development, are scheduled for orders. In its Q3 2025 results announcement, the company said earnings recovery was expected once the radiation management contracts for Wolsong Units 1 and 2 were reflected in results.

In April 2026 it said that, with its financial soundness and liquidity secured, it would expand investment in growing existing businesses.

The same month it sold part of its stake in the affiliate, keeping 17.81% as a strategic investor, and said it aims for meaningful results in nuclear decommissioning and radioactive waste treatment. The KF-21 supply contract is cited as a route to expand into defense parts.

The SMR business is at the memorandum of understanding stage, so the timing of any revenue contribution is not yet set. Revenue declined in both Q2 and Q3 2026, so the next annual report will show whether revenue recovers and which way the operating margin moves.

07

Valuation

PER
—
PBR
0.8×
ROE
-10.8%
EPS
-₩306
BPS
₩3,562
Dividend per share
₩0

The price-to-earnings ratio cannot be calculated because the last four quarters show net losses. The price-to-book ratio places the share price below book value per share, so the stock trades at a discount to net asset value rather than at a premium.

The dividend yield is effectively near zero, so little cash flow comes from dividends. Earnings-based multiples became hard to use as a benchmark after the 2024 swing to profit was followed by a return to loss in 2025.

On a capital basis, controlling-shareholder equity was KRW 62.5 billion of total equity of KRW 111.1 billion at the end of 2025, and the gap reflects non-controlling interests. The debt ratio rose to 109.2% in 2025 from 89.4% in 2024, which also enters any valuation reading given the higher debt burden against assets.

Earnings-based comparisons become possible again only when operating profit and controlling-shareholder net profit return to positive territory, so earnings recovery is the turning point for interpretation.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-17

08

Bull factors

If decommissioning approvals convert into orders

The bull case rests on decommissioning orders following Kori Unit 1 and Wolsong Unit 1 approvals, which could favor a company with decontamination and radiation management capabilities. The CEO said approval for those two units alone would open a KRW 3 trillion market over ten years.

Inspection and radiation management services for operating reactors already form a revenue base, so decommissioning orders would broaden the business mix.

Aerospace capacity investment and KF-21 supply

Aerospace accounts for 38% of total sales, and the company said it spent about KRW 5 billion in one year replacing aging equipment and adding production lines. The company expects earnings to improve once Boeing production volumes return to pre-COVID levels. The KF-21 machined parts contract is cited as a foothold for expanding into defense parts.

Liquidity support from asset sales and CB resale

The company resold its 7th-series convertible bonds, issued in 2024, for about KRW 11.2 billion to bolster cash liquidity. In April 2026 it sold part of its stake in an affiliate and said it would focus resources on core businesses.

It said that with financial soundness and liquidity secured, it would expand investment in higher-growth existing businesses.

09

Bear factors

Consecutive operating losses and falling sales

Operating losses have continued for five consecutive quarters from Q3 2025 through Q3 2026. Revenue declined in Q2 and Q3 2026, with Q3 at KRW 12 billion. The 2025 annual operating loss of KRW 14 billion followed a KRW 689 million operating profit in 2024.

Heavier debt burden and weaker cash flow

The debt ratio rose from 89.4% in 2024 to 109.2% in 2025, when total liabilities reached KRW 121.3 billion at year-end. Operating cash flow turned to a deficit of KRW 6.27 billion in 2025.

Controlling-shareholder net losses over the last four quarters total KRW 8.99 billion, so a clear trend of earnings reducing the debt burden has not yet emerged.

Net income volatility driven by non-operating items

Q1 2026 posted an operating loss of KRW 3.09 billion but a controlling-shareholder net profit of KRW 19.1 billion, and Q2 and Q3 then returned to net losses. Operating and net results moving in opposite directions make the quality of earnings hard to read. The SMR business is at the memorandum stage, so the timing of any revenue contribution is not set.

10

Risk factors

Policy and regulatory risk

Timing in nuclear decommissioning depends on approvals for Kori Unit 1 and Wolsong Unit 1 and on follow-on procurement schedules. A change in nuclear policy could delay service orders and decommissioning schedules. The KRW 3 trillion market figure is a CEO estimate and may differ from actual procurement.

Order and revenue volatility

In Q3 2025 the company said order timing slipped and revenue fell as a result. Revenue declines in Q2 and Q3 2026 show that quarterly results move with order timing. Aerospace results depend on the pace of Boeing production recovery and KF-21 volumes.

Financing and dilution risk

The company has relied on mezzanine financing such as convertible bonds, including the resale of its 2024 bonds for about KRW 11.2 billion. If the bonds convert into shares, existing shareholders could be diluted. With the debt ratio at 109.2% in 2025, financing terms could become a variable if further funding is needed.

11

What to watch next

  1. Around late February 2027

    Preliminary 2026 annual results, following the precedent of the 2025 annual disclosure on February 25, 2026. The key points are the size of the operating loss versus KRW 14 billion in 2025 and any swing to profit.

  2. By March 31, 2027

    Filing of the 2026 annual report. Full-year 2026 revenue and operating results will be confirmed on a DART regular-report basis, along with the finalized quarterly figures.

  3. By May 15, 2027

    The Q1 2027 quarterly report. It will show whether the KRW 19.1 billion controlling-shareholder profit seen in Q1 2026 reflected non-operating items, and whether operating profit has recovered.

  4. End of 2028

    Whether the 2028 revenue target of KRW 100 billion is reached. The pace of growth from KRW 57.9 billion in 2025 is the benchmark for judging the target.

  5. After December 2026 (timing not fixed)

    Follow-on procurement for Kori Unit 1 and Wolsong Unit 1 decommissioning, and tenders for radioactive waste decontamination projects. Order size and timing will determine when decommissioning revenue arrives.

12

Overall view

Orbitech is building nuclear decommissioning, aerospace parts and SMR as new pillars on top of its existing inspection and radiation management services for operating reactors.

On reported figures, operating profit turned positive in 2024, but 2025 swung back to an operating loss of KRW 14 billion, and operating losses have continued for five consecutive quarters through Q3 2026. Quarterly revenue fell from KRW 22.4 billion in Q1 2026 to KRW 12 billion in Q3, two straight quarterly declines.

Controlling-shareholder net losses over the last four quarters total KRW 8.99 billion, and the only profitable quarter in that span was Q1 2026, at KRW 19.1 billion. On the balance sheet, the debt ratio rose to 109.2% at the end of 2025, and operating cash flow turned negative.

Bull-side factors include approvals for Kori Unit 1 and Wolsong Unit 1, aerospace capacity investment and KF-21 supply, and liquidity support from asset sales and CB resales.

Bear-side factors include consecutive operating losses, quarterly revenue swings, dilution from convertible bonds, and dependence on policy timing. The next checkpoints are the 2028 revenue target of KRW 100 billion, the 2026 annual report, and whether the operating margin changes direction in the Q1 2027 results.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. disclo.co.kr
  2. pinpointnews.co.kr
  3. comp.fnguide.com
  4. joongangenews.com
  5. calculator.io.kr
  6. topdaily.kr
  7. topdaily.kr
  8. news.nate.com
  9. topdaily.kr
  10. hankyung.com
  11. kr.investing.com
  12. iprovest.com
  13. markets.hankyung.com
  14. navercomp.wisereport.co.kr
  15. jobkorea.co.kr
  16. meerae.ai
  17. investing.com
  18. alphasquare.co.kr

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.